Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic Transplantation.
Nozzoli C, Pucillo M, Giaccone L, Rambaldi A, Stanghellini MTL, Benedetti E, Russo D, Mordini N, Mangiacavalli S, Bernasconi P, Parma M, Carluccio P, Galieni P, Rivela P, Martino M, Chiusolo P, Isola M, De Martino M, Oldani E, Degrandi E, Boncompagni R, Antonioli E, Carnevale F, Tozzi M, Selleri C, Fanin R, Patriarca F; Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Nozzoli C, et al. Among authors: benedetti e.
Transplant Cell Ther. 2024 Nov 4:S2666-6367(24)00744-9. doi: 10.1016/j.jtct.2024.10.015. Online ahead of print.
Transplant Cell Ther. 2024.
PMID: 39505212